Newfound killer T cell could target most cancers

Researchers at Cardiff University (UK) have discovered a new type of killer T cell with a receptor that recognizes and kills most human cancer types. The study, published in Nature Immunology, has not yet been trialed in patients but has the potential to bring in a new era of broad-spectrum immunotherapies. T-cell therapies have sparked interest over the last few years as an alternative approach to cancer treatment. The most widely used therapy, CAR-T, is personalized to each patient but only targets a small number of cancers. Conventional T cells are able to selectively recognize and destroy cancerous cells expressing...